|
Speaker |
Presentation Title |
Time in CET |
Time in JST |
|
Prof. Toshiki Watanabe |
Chair Introduction |
10:00 - 10:05 am |
6:00 - 6:05 pm |
|
Prof. Atae Utsunomiya |
Current Status of ATL Clinical Practice and Treatment in Japan |
10:05 - 10:35 am |
6:05 - 6:35 pm |
| Prof. Yorifumi Sato | HTLV-1 Persistence and Pathogenesis: A Virological Perspective |
10:35 - 11:05 am |
6:35 - 7:05 pm |
|
Dr. Aileen Rowan |
Predicting the Development of ATL in HTLV-Carriers |
11:05 - 11:35 am |
7:05 - 7:35 pm |
|
Dr. Carolina Rosadas de Oliveira |
Harnessing Science and Collaboration to Advance Public Health Policies for HTLV |
11:35 - 12:05 pm |
7:35 - 8:05 pm |
|
Speaker |
Presentation Title |
Time in CET |
Time in JST |
|
Prof. Anne van den Broeke |
Towards the Clinical Validation of the Viral Clonality Evenness (VCE) Index: A Novel Prognostic Biomarker for Adult T-cell Leukemia |
10:00 - 10:30 am |
6:00 - 6:30 pm |
| Prof. Damian Purcell | Antivirals and RNA Vaccines to Prevent Human T-lymphotropic Retrovirus (HTLV-1) Infection and Disease |
10:30 - 11:00 am |
6:30 - 7:00 pm |
|
Prof. Makoto Yamagishi |
From Genomic and Epigenomic Maps to Medicines in Adult T-Cell Leukemia/Lymphoma |
11:00 - 11:30 am |
7:00 - 7:30 pm |
|
Prof. Yoshihisa Yamano |
Multiomics of HAM/TSP and Implications for Drug Discovery |
11:30 - 12:00 pm |
7:30 - 8:00 pm |
|
Prof. Toshiki Watanabe |
Closing of Webinar |
12:00 pm |
8:00 pm |